The risk of those potential harms, and of dying from alcohol-related causes, increases the more a person consumes.January 14, 2025Check out STAT+Sponsored By Brandon Bell/Getty Images Another federal report on alcohol finds even moderate drinking carries risks A new major federal report says having more than seven drinks per week carries a 1 in 1,000 risk of dying from alcohol use. By Isabella Cueto STAT+ | No longer a rocket ship, Teladoc promises stability to impress investors With days of rapid growth gone, virtual care company Teladoc's new CEO promised investors stability while speaking at the J.P. Morgan conference. By Mario Aguilar STAT+ | Former Trump FDA, CMS heads lay out how his return could reshape health policy At a STAT event, Scott Gottlieb and Seema Verma discussed how the administration could affect everything from vaccines to Medicare Advantage. By Jonathan Wosen Adobe Will MAHA add alcohol to its list of health foes? As health secretary, Robert F. Kennedy Jr. could try to sidestep politics and start a new alcohol temperance movement. By Isabella Cueto STAT+ | As deadline looms, health systems rush to ensure clinical algorithms don't discriminate By May, health systems must show that clinical algorithms they use don't discriminate based on protected traits such as sex and race. By Katie Palmer STAT+ | NIH issues a policy to widen access to medical products that emerge from government-funded research In explaining its move, the NIH acknowledged that "all too often, patients across the globe may be unable to access products they need." By Ed Silverman PATRICK T. FALLON/AFP via Getty Images Opinion: Raw milk can be safe — but it depends on something in short supply Think of a safe raw milk market as a three-legged milking stool, made up of health officials, consumers, and producers. By Bianca Garcia Q&A: How this federal court ruling helps nursing home residents with disabilities A recent federal ruling is expected to help nursing home residents with disabilities receive long-term care at home. By Timmy Broderick STAT+ | FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system The FTC noted that specialty generic drugs represent a large and growing amount of spending by plan sponsors and patients. By Ed Silverman More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments